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Abstract
Background: Graphene, a monolayer of carbon, is an engineered nanomaterial (ENM) with physical and chemical
properties that may offer application advantages over other carbonaceous ENMs, such as carbon nanotubes (CNT).
The goal of this study was to comparatively assess pulmonary and systemic toxicity of graphite nanoplates, a
member of the graphene-based nanomaterial family, with respect to nanoplate size.
Methods: Three sizes of graphite nanoplates [20 μm lateral (Gr20), 5 μm lateral (Gr5), and <2 μm lateral (Gr1)]
ranging from 8–25 nm in thickness were characterized for difference in surface area, structure,, zeta potential, and
agglomeration in dispersion medium, the vehicle for in vivo studies. Mice were exposed by pharyngeal aspiration
to these 3 sizes of graphite nanoplates at doses of 4 or 40 μg/mouse, or to carbon black (CB) as a carbonaceous
control material. At 4 h, 1 day, 7 days, 1 month, and 2 months post-exposure, bronchoalveolar lavage was
performed to collect fluid and cells for analysis of lung injury and inflammation. Particle clearance, histopathology
and gene expression in lung tissue were evaluated. In addition, protein levels and gene expression were measured
in blood, heart, aorta and liver to assess systemic responses.
Results: All Gr samples were found to be similarly composed of two graphite structures and agglomerated to
varying degrees in DM in proportion to the lateral dimension. Surface area for Gr1 was approximately 7-fold greater
than Gr5 and Gr20, but was less reactive reactive per m2. At the low dose, none of the Gr materials induced
toxicity. At the high dose, Gr20 and Gr5 exposure increased indices of lung inflammation and injury in lavage fluid
and tissue gene expression to a greater degree and duration than Gr1 and CB. Gr5 and Gr20 showed no or minimal
lung epithelial hypertrophy and hyperplasia, and no development of fibrosis by 2 months post-exposure. In
addition, the aorta and liver inflammatory and acute phase genes were transiently elevated in Gr5 and Gr20, relative
to Gr1.
Conclusions: Pulmonary and systemic toxicity of graphite nanoplates may be dependent on lateral size and/or
surface reactivity, with the graphite nanoplates > 5 μm laterally inducing greater toxicity which peaked at the early
time points post-exposure relative to the 1–2 μm graphite nanoplate.
Keywords: Graphene-based nanomaterials, Pulmonary exposure, Cardiovascular toxicity, Lung toxicity, Particle size
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Background
Graphene is chemically defined as a single-atom thick
layer of monocrystalline graphite, a two-dimensional sheet
of sp2-bonded carbon atoms arranged in a hexagonal pat-
tern. Following the first isolation and characterization of
graphene [1], research and production of “graphene-re-
lated” nanomaterials (one external dimension in the nano-
scale) has expanded exponentially [2]. The total forecasted
global market for graphene-based materials is tens of
billions and hundreds of billions of dollars for large
area graphene and bulk or flake graphene, respectively.
Applications are led by the field of electronics for large
area graphene and use in filtration by both the petrol-
eum and gas industry and the water/wastewater treat-
ment industry for bulk/flake graphene [2]. The global
market is predicted to grow considerably in the next
10 years. The current and potential applications of gra-
phene nanomaterials are numerous including, but not
limited to, use in electronics, energy storage, lighting,
filtration, aerospace engineering, sensors, structural en-
gineering composites, and health [2].
The unique physical and chemical properties of
graphene-based nanomaterials are the driving force be-
hind the rapid development and manufacturing of the
material [2, 3]. It is highly conductive, both electrically
and thermally, reactive to chemicals (“chemically tuned”),
has a high surface to weight ratio, and high curability for
its density. It is currently the thinnest material ever
made, is the most “stretchable” crystal ever made, and
is extremely strong. Because of their graphitic nature, gra-
phenes share some of the same industrially advantageous
properties as carbon nanotubes (CNTs), including strength,
conductivity, and density. In many instances it is consid-
ered to be superior to CNT. These factors include in-
creased surface area lending to increased conductivity,
decreased aspect ratio for less viscous resins which avoid
entanglement issues encountered with CNT, ease of access
to precursor material, and a more cost effective production
and scalability, all of which may lead to its replacement of
CNT in a number of applications [2]. With this growth
comes a risk for human exposure to the material along its
lifecycle of manufacturing, incorporation into products,
use of products, and end of life disposal. The size and
density properties of the graphene nanomaterial family,
along with known pulmonary toxicity associated with other
graphitic nanomaterials, such as CNT, present a concern
for respiratory exposure to these materials, particularly in
the workplace where the material is handled in powder
form prior to incorporation into a final product.
To date, there are a limited number of graphene nano-
material toxicology studies in vivo, and only a small
number of these focus on the respiratory route of expos-
ure [4–11]. To further complicate the interpretation and
comparison of in vitro and in vivo studies, terminology
related to graphitic nanomaterials has not been consist-
ent. The term “graphene” in industrial and toxicological
settings has come to refer to a family of materials that
includes any highly exfoliated graphite product [2]. This
family includes, but is not limited to, single layer graphene,
multi-layer and few-layer graphene, graphite nanosheets/
graphite nanoplates/graphite nanoflakes (ultrathin or ultra-
fine graphite), graphene nanosheets, graphene microsheets,
graphene nanoribbons, graphene oxide, graphite oxide,
and reduced graphene oxide. An effort has been made
to set forth a recommended nomenclature to better de-
fine these materials in terms of their physical/chemical
properties to remediate the issue [12, 13].
The current study investigated pulmonary and sys-
temic toxicity following pulmonary exposure to graphite
nanoplates or nanoplates, as defined by Bianco et al. [12].
Graphite nanoplates can have various industrial applica-
tions driven by different lateral dimensions. We hypothesize
that different lateral dimensions of graphite nanoplates will
confer different toxicity. In the development of structure
activity relationship (SAR) models, there is an increasing
need for studies that delineate the role of various physico-
chemical properties in particle toxicity. There are currently
no in vivo comparative toxicity studies on graphene that
have evaluated the role of lateral dimension in graphene
toxicity. Mice were exposed by a single oropharyngeal as-
piration to one of three different sizes of graphite nano-
plates suspended in a physiological dispersion medium [14]
at a dose of 4 or 40 μg per mouse, dispersion medium con-
trol, or carbon black at a dose of 40 μg as a carbonaceous
particle control. Parameters of lung injury, inflammation,
and oxidative stress, were assessed in lung tissue and bron-
choalveolar lavage (BAL) fluid at 4 h, 1 day, 7 days, 1 month,
and 2 months post-exposure. Lung histopathology and par-
ticle deposition and clearance were also evaluated. Systemic
response to lung exposure was assessed as alterations in
protein and gene expression in serum, whole blood, heart,
aorta, and liver at the same pulmonary recovery time
points. Results of the study indicate that the graphite nano-
plates with larger lateral dimensions induced a greater level
of toxicity in the lung and systemically following exposure
when compared to smaller graphite nanoplates, and re-




Field emission scanning electron microscopy (FESEM)
was employed to visualize the lateral dimension of the
primary particle size of the samples in dry powder form
(Fig. 1). The samples were manufactured to have primary
particle dimensions of ~ 20 μm lateral (Gr20; Fig. 1a),
5 μm lateral (Gr5; Fig. 1b), and < 2 μm lateral (Gr1; Fig. 1c).
Carbon black (CB; Fig. 1d) primary particles were ~20 nm
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in diameter. X-ray diffraction (XRD) analysis revealed that
Gr samples in this study were similar in structure and
consisted of two graphitic structures: hexagonal (2H) and
rhombohedral (3R), where ABA and ABCA represent
stacked graphitic layers (Fig. 2a&b). The graphitic pattern
for CB could not be resolved, with no identifiable peaks.
Graphite layers in the Gr samples were inversely related to
surface area (Fig. 2c). Gr20 and Gr5 were similar in
number of layers and surface area, with the lowest surface
area, ~ 3-fold lower than CB and 7-fold lower than Gr1. A
single layer of unoxidized graphene is 0.34 nm in thick-
ness [15] therefore the average nanoplate thicknesses were
calculated to be ~21 nm, ~25 nm and ~8 nm for Gr20,
Gr5 and Gr1, respectively, based on the number of
graphene layers quantified by XRD. These average thick-
nesses were greater than what would be predicted by a
geometric analysis of the surface area.
Agglomeration, stability, and surface impurity/reactivity in
DM
Agglomeration in dispersion medium (DM; in vivo deliv-
ery vehicle) was measured using morphometric point
count measurements. Figure 3 illustrates the average ag-
glomerate distributions of the samples prepared for in
vivo delivery. The average cross sectional measures of
the agglomerates/particles were 12.01, 5.56, 1.96, and
1.63 μm for Gr20, Gr5, Gr1, and CB, respectively. Ag-
glomerate size ranged up to 300 μm and 60 μm for the
Gr20 and Gr5 samples, respectively. Additionally, dynamic
light scattering (DLS) was used to measure agglomerate
size distribution for Gr1 and CB, resulting in a range of
0.222–2.035 μm for Gr1 and 0.146–2.172 μm for CB.
Gr20 and Gr5 agglomerates did not remain in suspension
long enough to accurately size and exceeded the size
limitation of the DLS. Zeta potential of particles in DM
did not differ between samples: CB = −17.4 ± 0.507;
Gr1 =−19.9 ± 0.161, Gr5 =−21.3 ± 0.242; and Gr20 =−18.1 ±
0.174 (values are means ± SE), indicative of moderate
instability of the agglomerates in all samples in DM.
Surface reactivity was assessed via 3 different methods,
electron spin resonance (ESR), dichlorofluorescin (DCFH)
oxidation assay, and antioxidant (dithiothreitol, DTT) de-
pletion. The generation of radicals on the surface of parti-
cles in DM in the presence of hydrogen peroxide as an
index of impurities of the surface that can contribute to
surface reactivity was measured using electron spin res-
onance (ESR) and compared to a positive carbonaceous
control particle, coal containing α-quartz silica. The
generation of radicals by this method was negligible as
compared to that of the positive control (data not shown)
indicating the particles had very low surface reactivity, and
generation of radicals between graphene samples did not
differ. Using the dichlorofluorescin (DCFH) assay, al-
though we could see a dose- and time-dependent change
in DCFH fluorescence, at all time points measured the
fluorescence values from the nanomaterials was lower
than what was observed for DM or water control (data
not shown). Addition of horseradish peroxidase (HRP) in
the reaction mixture amplified the DCFH oxidation and
the fluorescence values by 3-fold or higher but did not
Fig. 1 FESEM Images Illustrating Primary Particle Size. FESEM images of dry powder samples of Gr20 (a), Gr5 (b), Gr1 (c), and CB (d) at the same
magnification illustrating the difference in size of the primary particle. c Gr1 Inset: High magnification of the Gr1 sample showing the flake-like
structure of the particle similar to that of Gr20 and Gr5, but on a much smaller scale. d CB Inset: High magnification of CB shows the primary particles
at ~ 20 nm diameter
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change the trend that was observed without HRP. The
acellular DCFH assay suffered from high background sig-
nal resulting from either dye auto-oxidation or as a result
of fluorescence quenching by carbonaceous materials. The
third cell free assay system, the dithiothreitol (DTT) assay,
which is based on antioxidant depletion to determine the
oxidative potential of the materials, was performed and
data was evaluated in terms of mass of material (Fig. 4a)
as well as surface area (Fig. 4b). On a mass basis, Gr1 and
Gr5 showed a greater consumption of DTT as compared
to Gr20 and CB (Fig. 4a). However, upon normalizing to
surface area of the material as measured by BET (Fig. 4b),
Gr5 showed the greatest consumption of DTT, followed
by Gr20. Both Gr5 and Gr20 showed increased DTT con-
sumption per m2 when compared to Gr1 and CB. Gr1
and CB did not differ from each other.
In vivo studies
Deposition/Clearance
Particle deposition (Fig. 5) and clearance (Fig. 6) were
evaluated morphometrically in animals exposed to the
high doses of particles at 4 h following aspiration. At this
time point, all particles were found in both lower air-
ways and alveoli with the majority of all particles located
in alveoli (greater than 80 %). However, particle depos-
ition in airways varied slightly with particle size, with a
slightly greater degree of airway deposition in the Gr5
and CB samples (Fig. 5). Gr20 and Gr1 had a slightly
greater deposition in the alveolar region. These differ-
ences were not significant. It should be noted that this
evaluation may under estimate the total burden, as de-
position in large conducting airways was not evaluated.
This may be particularly significant for the Gr20 and
Gr5 groups as these groups had the larger agglomerate
sizes which may have deposited in those larger airways.
In general, there tends to be less deposition in these lar-
ger airways with the exception of very large agglomer-
ates which would be cleared very quickly. At 2 months,
a greater amount of Gr5 persisted in the lungs when
compared to all other particles (Fig. 6). The majority of
the burden remaining in the lung at 2 months in mice
exposed to Gr20 and CB was found to be located pri-
marily in the alveoli; whereas in mice exposed to Gr5
and Gr1, the remaining lung burden was found to be
approximately 60 % alveolar in the Gr5 group and 20 %
alveolar in the Gr1 group. At all time points post-
exposure and in all treatment groups, macrophages re-
covered by bronchoalveolar lavage (BAL) were observed
to contain particles. Images of BAL cells are depicted in
Additional file 1: Figure S1 for the 4 h, 7 day, and
2 month time points. In the Gr20 and Gr5 groups, clus-
ters of macrophages were observed in conjunction with
the larger agglomerates. At 2 months post-exposure,
Gr5 and CB groups appear to have a greater burden per
macrophage than the Gr20 and Gr1 groups, which is in
agreement with the morphometric analysis of lung
clearance. In the Gr20 group, the majority of particles
recovered in the BAL were larger agglomerates associ-
ated with groups of macrophages, rather than macro-
phages containing smaller agglomerates as observed in
the Gr5 group at that time point. Multinucleated mac-
rophages can be observed in the Gr5 and Gr20 groups
at the 2 month time-point; however, these were rela-





Fig. 2 XRD and BET Analysis of Gr and CB Samples. a Crystaline
structures of Gr samples in this study consisted of two graphitic
structures: hexagonal (2H) and rhombohedral (3R), where ABA and
ABCA represent stacked graphitic layers. b XRD pattern of Gr20 with
the Bragg lines identified with 2H, 3R, and 2H/3R phases of graphite.
Gr5 and Gr1 had similar patterns, with slightly less pronounced peaks
for Gr1. The XRD pattern of CB consist of broad peaks near 2-theta = 24o
and 44o typical of disordered carbons. c Table summary of surface area
of dry powder samples assess using the BET method and the number
of layers/sheets in each sample determined by XRD
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Histopathology
Histopathological analysis for alveolar interstitial inflam-
mation (AII), bronchiolar inflammation (BI), terminal
bronchiolar inflammation (TBI), and bronchiolar hyper-
trophy or hyperplasia (BHH) was performed at 7 days,
1 month, and 2 months post-exposure for all treatment
groups (n = 6 per group per time point) (Table 1). The
presence of type II epithelial cell hypertrophy, bronchus-
associated lymphoid tissue (BALT), lipidosis, and fibrosis
was also evaluated. Alterations were scored from 0–5 for
severity. No pathological changes were found in animals
exposed to DM, low doses of Gr samples, or the high
dose of Gr1. On day 7, TBI was noted as minimal in the
Gr20 (average score = 1.2), Gr5 (average score = 1), and
CB (average score = 0.5) groups. BHH was also scored as
minimal in the Gr20 group (average score = 1) at day 7.
One animal in the Gr20 group showed BI on day 7. No
changes were noted in the CB group at 1 or 2 months.
BHH persisted as minimal in the Gr20 group through-
out the time course (average score of 0.7 and 0.8 at 1
and 2 months), and was also observed to be minimal in
the Gr5 group at 1 and 2 months (average score of 0.5).
TBI also persisted as minimal in the Gr20 group with
decreased severity over time (average score =0.7 at
2 months). TBI decreased over time in the Gr5 group and
was not observed at 2 months. Minimal AII (score = 1)
was only observed in 2 animals in the Gr5 group at
2 months. One fibrotic focal area was noted in 1 animal
from the Gr20 group at 2 months and was scored as min-
imal (n = 1). No fibrosis, lipidosis, granulomatous forma-
tions, type II pneumocyte hypertrophy or development of
BALT was noted. Although animals exposed to the larger
Gr samples were noted to have a higher degree of inflam-
mation, severity either remained level or decreased over
time suggesting no overt disease associated with exposure.
Bronchoalveolar Lavage (BAL) analysis
Cell counts and differentials were performed on cells
recovered by BAL at 4 h, 1 day, 7 days, 1 month and
2 months post-exposure (Fig. 7). Neutrophil influx was
greatest in the CB reference particle group relative to
all other groups at 1 day post-exposure, but was not in-
creased in the CB group relative to DM at any other time
point (Fig. 7b). Gr1 also had an increase in neutrophil in-
flux only at 1 day post-exposure, a similar pattern to CB
albeit to a lesser degree. Exposure to the larger sizes of
graphite nanoplates (Gr20 and Gr5) at the high dose sig-
nificantly increased neutrophils in the lungs up to 1 month
post-exposure, peaking at the 4 h time point and decreas-
ing over time relative to control and to the low dose
a b
c d
Fig. 3 Particle Agglomeration. Light micrographs of the high dose aspiration preparations (0.8 mg/ml DM) of Gr20 (a), Gr5 (b), Gr1 (c), and CB (d).
Table Insets: Corresponding agglomerate/particle diameter size distributions made from point count measurements on the light microscope
(n= 214-491 measures). The average cross sectional measures of the agglomerates/particles were 12.01, 5.56, 1.96, and 1.63 μm for Gr20, Gr5,
Gr1, and CB, respectively. Agglomerate size ranged up to 300 μm and 60 μm for the Gr20 and Gr5 samples, respectively. Additionally, dynamic
light scattering (DLS) was used to measure agglomerate size distribution for Gr1 and CB, resulting in a range of 0.222-2.035 μm for Gr1 and
0.146-2.172 μm for CB. Gr20 and Gr5 did not remain in suspension long enough to accurately size agglomerates using DLS
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groups (Fig. 7b Increases in eosinophils followed a similar
pattern as neutrophil influx peaking on 1 day post-
exposure for the Gr5 and Gr20 groups (Fig. 7c); however,
no increase in eosinophils was found in the CB or Gr1
groups. A non-significant increase in lymphocytes was ob-
served only at 7 days post-exposure in the Gr5 and Gr20
group (data not shown), and there were no significant dif-
ferences in macrophage influx (Fig. 7a) into the lungs of
treated mice.
BAL fluid (BALF) was analyzed for the presence of
lactate dehydrogenase (LDH) activity as an index of
cytotoxicity and lung injury (Fig. 8). Exposure to the
larger sizes of graphite nanoplates (Gr20 and Gr5) at
the high dose increased LDH at 4 h and 1 day post-
exposure. Although injury was still significantly in-
creased at 1 month post-exposure, LDH activity levels
began decreasing over time after 1 day, and had returned
to control levels by 2 months, indicating resolution of lung
injury over time.
A panel of 60 proteins (Additional file 2: Table S1) in
BALF was measured reflecting the activity of cellular
pathways including chemotaxis, inflammation, oxidative
stress, tissue remodeling, and immune response. No sig-
nificant differences were observed in the low dose groups
at 1 day post-exposure, and proteins in the low dose
groups were, consequently, not analyzed at the later time
points post-exposure. At 1 day post-exposure, ~40 of the
60 proteins measured in the BALF, related primarily to in-
flammation, acute phase response, chemotaxis, and tissue
remodeling pathways, as well as some immune-regulatory
responses, were elevated differentially as follows in ani-
mals exposed to the high doses of particles when com-
pared to DM: Gr5 > CB ≥Gr20 > Gr1 (Table 2). The
exception to the rule occurred with interleukin (IL)-5 and
tissue inhibitor of metalloproteinase (TIMP)-1, as well as
a trend for matrix metalloproteinase (MMP)-9, where
Gr20 and Gr5 produced a similar response to each other
that was greater than that of the CB group. Levels of all
significantly elevated proteins on day 1 decreased over
time for all groups to varying degrees. At 7 days and
1 month post-exposure, several proteins remained signifi-
cantly elevated for Gr5 and Gr20, while no significant
changes were evident at 1 month post-exposure for the
CB- or Gr1-treated groups. Proteins elevated at 1 month
in the Gr20 and Gr5 groups were primarily indicative of
inflammation/chemotaxis (macrophage colony stimulating
factor, macrophage inflammatory proteins, macrophage –
derived chemokine, myeloperoxidase), and tissue remodel-
ing (MMP-9, TIMP-1, and fibrinogen). The data indicate
that the larger graphite nanoplates may be producing a
greater degree of persistent inflammation and injury in
the lung. A similar battery of protein analysis in BALF was
conducted for the DM, Gr5 and Gr20 high dose groups
only at 2 months post-exposure (Table 3). Overall, protein
concentrations in BALF continued to decrease in Gr5 and
Gr20 groups over the time course. Although there were a
greater number of proteins that remained significantly
elevated in the Gr5 group versus the Gr20 group when
compared to DM (primarily related to inflammation/
chemotaxis), the fold-increase was lower than that of
the early time points indicating resolution of most re-
sponses. The differences that existed may relate to lung
burden at 2 months following exposure, where animals
exposed to the high dose of Gr5 had the slowest par-
ticle clearance rate with ~60 % of particles persisting in
the alveolar region at that time.
Relative mRNA expression from lung
A screen of 93 target genes (Additional file 3: Table S2)
was analyzed for the lung. Categorically, these genes rep-
resent mediators of tissue remodeling, inflammation/acute
phase response, immune response, chemotaxis, endothelial
cell activation, oxidative stress, coagulation, and cellular
















































Fig. 4 Surface Reactivity by Antioxidant Depletion. Antioxidant
(DTT, dithiothreitol) depletion by particles prepared in DM (50 μg/ml)
following the same procedures as preparation for aspiration in mice.
Data is presented as total DTT consumed on a mass basis (a), including
the background measurement for the vehicle (DM), and as DTT
consumed normalized to surface area (b). a- significantly different
from the reference material, CB; b- significantly different from all
particles; p < 0.05
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lifecycle/apoptosis pathways. At 4 h post-exposure, signifi-
cant alterations in relative expression of various mediators
were observed (Additional file 4: Table S3). These media-
tors related largely to the inflammation/acute phase and
chemotaxis/endothelial cell activation pathways, and sev-
eral immune response and tissue remodeling genes were
also increased, complementing the protein data obtained
in the BALF. In general, the effects were greater in the
Gr20- and Gr5-exposed mice compared to Gr1. At 1 day
post-exposure, similar potency was observed with re-
sponses being greater in Gr20- and Gr5-exposed mice
compared to Gr1 (Additional file 4: Table S3). In a tem-
poral fashion, the level of response was less at 1 day as
compared to 4 h post-exposure. A subset of genes includ-
ing Il6, Cxcl2, Ccl2, and Ccl22 were further examined and
showed a general resolution with time when evaluating all
Gr20 Gr5
BC1rG
Fig. 5 Particle Deposition Following Aspiration. Hematoxylin and eosin-stained lung tissue sections 4 h after mice were exposed to 40 μg of
Gr20, Gr5, Gr1, or CB showing differential deposition of particles (Blue arrow heads = particle uptake in macrophages; green arrows = particles in
airspace; 60x magnification). All particles were found in both airways and alveoli with majority of all particles located in alveoli (greater than 80 %
for all groups), with slight variations in airway deposition depending upon particle size






















Fig. 6 Lung Clearance of Particles. Morphometric analysis of pulmonary clearance of Gr20, Gr5, Gr1, and CB over the 2 month time course
assuming 100 % burden at 4 h post-exposure. At 2 months, a greater amount of Gr5 persisted in the lungs when compared to all other particles.
The majority of the burden remaining in the lung at 2 months in mice exposed to Gr20 and CB was found to be located primarily in the alveoli
(hatched area of bar); whereas Gr5 and Gr1 had greater remaining burden distributed in airways
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post-exposure time points (Fig. 9). Il6 represents a primary
inflammatory cytokine which stimulates the immune and
acute phase response. Cxcl2 is an indicator of the neutro-
phil response while Ccl2 indicates macrophage activation.
Ccl22 also indicates macrophage, and potentially dendritic
cell activation. Ccl22 was related to declining lung function
following a particulate exposure [16, 17] and persists lon-
ger than other traditional mediators [18], hence its inclu-
sion in thepnale of toxicity markers. The effects were more
sustained in the Gr20 and Gr5 groups when compared to
Gr1 for those four genes. CB was similar to Gr1 in that
acute inflammation was observed at early time points with
resolution observed by day 7. The low doses of Gr20 and
Gr5 showed initial inflammation at 4 h with increased ex-
pression of Il6, Cxcl2, and Ccl2 that resolved by 1 day post-
exposure. The expression of osteopontin, Spp1, which can
be suggestive of granuloma production as well as other im-
mune responses in lung tissue, increased with time reach-
ing significance at the later time points for Gr20 and Gr5.
Screen for systemic responses
The same battery of proteins analyzed in BALF was ana-
lyzed in the serum at 4 h and 1 day post-exposure for
DM and high dose groups including CB (Fig. 10a). In
general, effects were greater in the Gr20 and Gr5 groups
in comparison to Gr1. KC/GRO was the only protein found
to be increased in serum collected from Gr1-exposed mice
at 4 h post-exposure. KC/GRO, IL-6, and TIMP-1 were in-
creased 4 h post-exposure in the CB exposed mice, corre-
sponding to elevations in RNA levels at that time
(Additional file 4: Table S3). The only mediator found to be
increased in serum by 1 day post-exposure was TIMP-1 in
the Gr20- and Gr5-exposed mice. No mediators were
elevated in the Gr1 or CB groups at 1 day. Expression of
liver acute phase genes, Apcs, Saa1, and Hp was assessed in
the high dose groups only, and were found to be increased
for the Gr20, Gr5, and CB groups (Fig. 10b). There was no
change with Gr1 exposure at the high dose. Relative mRNA
expression from whole blood cells was screened by the pre-
designed array (Additional file 3: Table S2) and several
genes were confirmed by qPCR (Fig. 10c). All genes ana-
lyzed by qPCR were significantly increased in the Gr5 high
dose. High dose exposure to Gr20, Gr1, and CB resulted in
at least 2 genes significantly increased in each group. There
was a decrease in oxidant protective genes (Sod2 -1.79;
Cat -1.96; Nqo1 -1.64 fold change) in the Gr5 group
compared to DM in the analysis of the pre-designed
array. No effects were seen in the low dose exposures.
In the aorta, although there was a general trend for al-
tered gene expression in the Gr20 high dose group,
there were no significant increases in any of the genes
selected for screening (Fig. 10d).
Discussion
There is currently very little information available on
airborne concentrations of graphene-based or graphite
nanomaterials in occupational settings with the excep-
tion of one study by Lo et al. [19], that examined engin-
eering controls for graphene platelets at a facility during
manufacturing and handling processes where the highest
concentrations were recorded at 2x106 particles/cm3 dur-
ing a post-treatment process. Based on the current lack of
relevant workplace exposure data, doses for the present
study were selected based on previous research that inves-
tigated toxicity of MWCNT Mitsui 7, a relatively toxic
carbonaceous nanomaterial know to produce lung fibrosis
Table 1 Histopathology analysis of lung tissue following exposure to 40 μg of particles
Treatment Group Time Post-Exposure AII BI TBI BHH
Gr20 7 day - 0.17 (1/6) 1.7 (6/6) 1.0 (5/6)
Gr5 7 day - - 1.0 (5/6) -
Gr1 7 day - - - -
CB 7 day - - 0.5 (3/6) 0.17 (1/6)
Gr20 1 month 0.17 (1/6) - 0.7 (4/6) 0.7 (4/6)
Gr5 1 month - - 0.7 (2/6) 0.5 (3/6)
Gr1 1 month - - - -
CB 1 month - - - -
Gr20 2 months - - 0.7 (4/6) 0.83 (5/6)
Gr5 2 months 0.3 (2/6) - - 0.5 (3/6)
Gr1 2 months - - - -
CB 2 months - - - -
Lung tissue was analyzed for alveolar interstitial inflammation (AII), bronchiolar inflammation (BI), terminal bronchiolar inflammation (TBI), and bronchiolar hypertrophy
or hyperplasia (BHH), type II cell hypertrophy, BALT, lipidosis, fibrosis (n = 6 per group per time point). Severity was scored as 0-5: 0 = normal, 1 =minimal/slight, 2 =mild,
3 =moderate, 4 =marked, and 5 = severe. Data are presented as means in bold with incidence (number of animals with a positive score per total animals) in
parentheses. No changes in type II cell hypertrophy, BALT, lipidosis, or fibrosis were noted with the exception of one 1 animal from the Gr20 group at 2 months
that had one fibrotic focal area scored as 1
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[18, 20] and recently categorized by the International
Agency for Research on Cancer (IARC) as a Group 2B
(possibly carcinogenic to humans) [21, 22], for control
purposes. A previous study showed that approximately
40 μg of MWCNT in the lung was equivalent to 76 years
of a worker at the average facility exposure levels, and
4 μg was equivalent to 7.6 years, representing a more rele-
vant worker exposure [18, 20]. While detailed exposure
assessments have not been performed in facilities that
handle graphene, the end-product applications have simi-
larities to MWCNT and dry powder handling would be
expected [23]. Therefore, the doses selected in this study
were based on the MWCNT studies to attempt to reflect
relevant workforce exposures (4 μg) and developing path-
ology (40 μg) as an early tier screen for general toxicity
and potency classification of graphite nanoplates.
The goal of the current study was to characterize pul-
monary and systemic toxicity associated with lung ex-
posure to non-oxidized graphite nanoplates, a member
of the graphene nanomaterial family, with respect to
variation in lateral size of the material. To date, this is
the first in vivo study to perform a size comparison of
graphene nanomaterials of like composition. The mate-
rials investigated in these studies were identical in terms
of structural and chemical composition, and zeta poten-
tial in the vehicle control (indicative of stability in solu-
tion and surface charge). The materials were also shown
to be identical in terms of surface impurities that may
contribute to reactivity as measured by ESR; however, in
an acellular assay to determine reactivity by evidence of
antioxidant depletion (Fig. 4), on a mass basis the order
of reactivity followed as Gr1 > Gr5 > Gr20 ≥CB. When
normalizing the data to the surface are, it was found that
reactivity was greatest for the Gr5 sample followed by
the Gr20 sample, and was lowest for the Gr1 and CB
which were comparable to each other. The materials also
differed in lateral dimension, layer number (thickness),
surface area, and degree of agglomeration in DM. All
materials were found to agglomerate in DM, and the ag-
glomerate size ranges varied in proportion to the lateral
dimension.
Mice in the current studies were exposed to 4 or
40 μg of either Gr20 (~12 μm lateral x ~21 nm or 72
layers thick), Gr5 (~5 μm lateral x ~25 nm or 84 layers
thick), Gr1 (~2 μm lateral x ~8 nm or 28 nm thick), or
CB (~20 nm diameter) as a reference particle, in DM by
a single pharyngeal aspiration. The flake or platelet-like
shape presents a challenge in estimating deposition in
the lung. Sanchez et al. [15] developed a model predict-
ing regional deposition of plate-shaped materials with
0.5, 5, or 25 μm diameter in the lateral dimension relative
to layer number, illustrating an alveolar deposition effi-
ciency as high as 45 % for the small particle and up to
10 % for the largest particle. Additionally, Schinwald et al.
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Fig. 7 Cellular Differentials in Bronchoalveolar Lavage. Total BAL
cells recovered from mice 4 h, 1 day, 7 days, 1 month, and 2 months
post-exposure to 4 or 40 μg of Gr20, Gr5, or Gr1, 40 μg of CB, or DM
alone differentiated into AM (a), neutrophils (b), and eosinophils (c)
(lymphocytes not shown). *significantly different from all groups; +
significantly different from DM, Gr20-Low, Gr5-Low, Gr1-Low, Gr1-High,
and CB; ^significantly different from DM, Gr20-Low, Gr5-Low, and
Gr1-Low; p < 0.05
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[8] developed a calculation for the aerodynamic diameter
of plate-like particles taking into account thickness,
diameter, and densities, demonstrating that a particle
with a lateral dimension of up to 30 μm would have an
aerodynamic diameter of only 3.26 μm. These models
collectively indicate that all three graphite nanoplate
samples in the study presented here, Gr20, Gr5, and
Gr1, would be considered respirable in humans.
The findings of this study showed that the systemic re-
sponse following pulmonary exposure was transient. The
greatest responses in liver and blood (cells and serum)
were observed at 4 h and 1 day post-exposure (Fig. 10)
in the high dose Gr20 and Gr5 groups, followed by the
CB then Gr groups. These responses did not persist be-
yond the early time points post-exposure. Histopatho-
logical evaluation of the three graphite nanoplates
showed no evidence of the development of fibrosis or
granulomatous lung disease. The only histologic changes
in the lung were related to injury and inflammation and
were observed in the Gr20 and Gr5 groups scored as
minimal. These responses either resolved over time or
remained minimal at 2 months following exposure. No
pulmonary inflammation was observed at the low dose
exposures in any of the Gr groups, a dose that may
prove to be more occupationally relevant based on find-
ings from MWCNT facility studies discussed above.
The greatest changes were observed in the lung at the
high doses of the larger sizes of graphite nanoplates in
terms of inflammation, relative to that of Gr1. Increased
inflammation was demonstrated as BAL granulocyte in-
filtration into the lung (neutrophils and eosinophils;
Fig. 7b&c) and increased chemokines/cytokines in BAL
fluid (Tables 2 and 3) following high dose exposure to
the larger Gr20 and Gr5 particles beginning at 4 h post-
exposure. The increase peaked at 1 day and persisted up
to 1–2 months following exposure, with a trend for a de-
crease over time. Inflammation measured as neutrophil
influx was present only at 1 day post-exposure in the
high dose Gr1 and CB groups, and to the greatest degree
in the CB group relative to all groups at this time point,
agreeing with the largest induction of MIP-2 (Cxcl2) and
KC (Cxcl1) (Table 2). No eosinophil influx was observed
for the CB or Gr1 groups, corresponding with minimal
changes in IL-5 and eotaxin in comparison to Gr5 and
Gr20 (Table 2). Similar patterns in cytokine responses,
whereby elevations persist for longer duration for the
Gr5 and Gr20 groups, are also evident and are discussed
below. These differential responses to particle exposure
may be related to differences in the physico-chemical
properties of the materials. In addition to the larger lat-
eral dimensions and agglomerate structures of Gr5 and
Gr20, these two particle were more reactive when nor-
malized to surface area of the material. These character-
istics may provide a possible explanation for inducing an
earlier (4 h post-exposure) and more persistent response
over time as compared to the high surface area materials
of CB and Gr1, which caused cellular inflammation at
only at day 1 post-exposure. Interestingly, the greatest
degree of neutrophil influx at day 1 was caused by CB
relative to the other Gr materials, including Gr1 which
has twice the surface area as CB. Particle size in the
acute response may also be playing a role in the strong
Times (Post-Exposure)



















Gr20 - Low 
Gr20 - High 
Gr5 - Low 
Gr5 - High 
Gr1 - Low 







Fig. 8 Lung Injury. Lactate dehydrogenase (LDH) activity, an indicator of cytotoxicity, in BALF recovered from mice 4 h, 1 day, 7 days, 1 month,
and 2 months post-exposure to 4 or 40 μg of Gr20, Gr5, or Gr1, 40 μg of CB, or DM alone. +significantly different from DM, Gr20-Low, Gr5-Low,
Gr1- Low, Gr1-High, and CB; #significantly different from DM, Gr5-Low, and Gr1-Low; ^significantly different from DM, Gr20-Low, Gr5-Low, and
Gr1-Low; p < 0.05
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Table 2 BALF protein analysis at 1 day, 7 days and 1 month

























Apo A-1 3.44b,c 3.02b,c 1.54 2.57b 0.98 0.76 0.73 0.48 1.26 1.34 1.24 0.94
CRP Mouse 1.94c 1.53c 1.18 1.29 1.07 1.07 0.80 1.00 1.29 1.21 1.29 1.07
CD40 BLD BLD BLD 1.36e BLD 1.63 BLD 1.69 BLD BLD BLD BLD
CD40L 26.74c 35.13c 9.3b 33.74c 2.41 2.76 0.97 3.04 1.00 1.13 0.62 0.78
Eotaxin 3.2c 6.46c 1.36b 2.04c 1.46 1.56 1.22 1.22 1.07 1.08 1.10 0.94
EGF Mouse 2.63b,c 3.12c 2.34b 3.12c 2.46a 2.28a 2.06a 2.02a 0.84 0.94 0.68 0.68
Factor VII 1.83b 2.53c 1.66b 2.23c 1.73 1.41 1.47 1.39 1.08 1.11 1.07 0.98
Fibrinogen 2.77c 2.35c 1.26 2.07c 1.29 0.94 0.79 1.12 1.35a 1.28 1.23 1.11
GCP-2 Mouse 1.83b 2.70c 2.94c 3.17c 2.12c 1.71c 2.27c 1.68 1.04 0.89 0.70 0.97
GM-CSF 2.39b 5.75c 4.49c 24.48e 2.02 1.36 1.71 1.18 1.15 1.06 0.87 0.92
KC/GRO 4.17b 12.5c 7.08c 23.33e BLD BLD BLD BLD BLD BLD BLD BLD
IgA 0.93 1.64 1.00 1.30 0.86 0.84 0.80 0.65 1.18 1.00 0.99 1.03
IP-10 10.76b 14.28b 1.98 7.59b 1.48 1.58 1.48 2.47 0.84 1.02 0.93 1.02
IL-1α 1.86b 2.66c 1.78b 3.32c 2.45 3.46 2.62 2.57 1.26 1.55 0.42 1.31
IL-1β 1.26 2.00 1.01 2.08c 0.99 1.03 0.82 0.87 0.72 1.22 1.32 1.12
IL-5 6.22d 8.49d 1.26 2.26c BLD BLD BLD BLD BLD BLD BLD BLD
IL-6 16.34c 39.02e 4.65b 13.99c BLD BLD BLD BLD BLD BLD BLD BLD
IL-18 1.60b 2.26c 1.50b 2.74c 0.99 1.35 0.96 1.10 0.81 1.17 0.92 1.06
LIF 3.91c 6.57d 1.99b 3.01c 2.25a 1.81 1.89 1.62 1.00 0.98 0.81 0.87
Lymphotactin 1.61 2.39c 1.14 1.91 1.18 1.10 1.17 1.42 0.62 0.81 1.00 1.01
M-CSF-1 1.62b 2.31c 1.62b 3.91e 1.32 1.22 1.03 1.19 1.18c 1.27c 0.97 0.92
MDC 6.04c 8.58e 1.78 4.09c 2.34a 1.84a 1.51a 1.78a 1.63c 1.76c 1.10 1.36
MIP-1α 2.84c 4.12d 1.70b 3.56d 2.50 2.32 2.40 1.71 1.82 3.33b 1.81 1.50
MIP-1β 14.51c 14.99c 3.09b 12.94c 1.40 1.79 1.46 2.13 0.82 1.25 0.75 0.74
MIP-1γ 6.33c 9.03c 3.94b 10.35c 2.95a 3.78a 1.38 2.11 2.75c 3.69c 1.30 1.69
MIP-2 4.54c 5.54c 2.94b 5.70c 2.26a 1.93 1.89 1.76 0.76 0.96 0.60 0.85
MIP-3 2.34c 3.56e 1.78b 2.50c 2.13a 2.08a 2.15a 1.95a 1.17 1.09 0.88 1.01
MMP-9 71.42c 52.44c 11.19b 46.72c 4.08 4.51 2.46 4.90 2.07c 1.87c 0.63 0.95
MCP-1 17.86c 25.76c 0.98 15.54c BLD BLD BLD 7.06 BLD BLD BLD BLD
MCP-3 38.32c 42.07c 3.01b 21.82c 1.18 3.57a 1.65a 5.56a 1.13 2.04e 0.97 1.05
MCP-5 9.27c 10.11c BLD 5.38c BLD BLD 0.73 1.03 BLD BLD BLD BLD
MPO 51.27c 66.02d 18.32c 62.77d 21.78a 20.26c 7.23a 25.24c 4.68c 3.58c 0.59 1.01
PAI-1 1.84c 2.63e 1.50b 1.64c 1.17 1.11 0.98 1.21 1.12 1.37 1.15 1.14
SAP 2.63b,c 2.03b 1.09 1.50 1.38 1.00 0.68 0.71 1.00 0.97 1.13 0.63
SCF 2.36b 3.37c 1.39 2.66c 0.88 1.43 1.51 2.09 1.26 0.88 0.82 0.83
Thrombopoetin 2.53b 4.17c 2.20b 4.42c 1.47 1.03 BLD BLD BLD 1.58 BLD BLD
TIMP-1 17.32d 18.88d 2.95b 7.49c 1.59 1.82a 1.12 1.18 1.37 1.53c 1.30 1.97
TNF-α BLD 3.90e BLD BLD BLD BLD BLD BLD BLD BLD BLD BLD
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neutrophil response as CB had the smallest primary
particle size of all the materials. Further investigation is
necessary to understand if this response could be re-
lated to the primary particle size in conjunction with
high surface area. In addition, differences in patterns of
inflammation and irritant response in relationship to
particle properties such as reactivity also warrants fur-
ther investigation.
Although the study was not designed to address mech-
anisms of toxicity related to specific cellular responses,
several points are worth discussion related to other in-
vestigations of graphene-based nanomaterials. In recent
years, formation of the NLRP3 inflammasome has been
implicated as having a role in pathways to inflammatory
diseases and fibrosis following particle or fiber exposure
in the lung [24], including high aspect ratio nanoparti-
cles such as MWCNT ([25–27]. Schinwald et al. [9] have
also demonstrated the likely formation of the inflamma-
some following graphene exposure. This study did not
directly assess inflammasome formation in relationship
to the acute inflammatory responses, however, two pro-
teins associated with the formation of the inflammasome
were measured, IL-18 and IL-1β. An increase in IL-18 in
BAL fluid was observed 1 day following exposure in all
high dose groups, and IL-1β was variably increased
among groups in BAL at this time point also. Gene ex-
pression analysis of IL-1β in lung tissue was also in-
creased at 4 h for all Gr exposures and at 1 day for the
Gr5 and Gr20 groups. As with most BAL protein param-
eters measured, the increased level of these proteins did
not persist beyond 1 day, with the exception of an in-
crease in IL-18 in the Gr5 group at 2 months. This study
currently does not provide enough inflammasome-
specific data to draw conclusions related to its likely
Table 2 BALF protein analysis at 1 day, 7 days and 1 month (Continued)
VCAM-1 1.88c 2.08c 1.30 1.86c 1.13 1.21 0.84 1.07 1.16 1.20 1.08 0.98
VEGF-A 2.16c 2.45c 1.44b 2.49c 1.14 1.08 1.04 1.04 0.96 0.98 0.93 0.85
vWF 1.76b 2.10b 1.73b 2.33c 1.63 1.63 1.52 1.29 1.22 1.11 1.00 1.05
Data in the table represent fold-increase for proteins that were significantly different for one or more groups at one or more time points post-exposure based on
RodentMap® v2.0. The low dose groups were tested only at 1 day post-exposure. BLD – below the limit of detection. Groups with like symbols denote statistically
similar group; astatistically different from DM only; bstatistically different from DM and all low dose groups; cstatistically different from DM and at least one high
dose group; dstatistically different from statistically different from DM, low dose groups, and at least one high dose group; estatistically different from all groups;
p < 0.05. Bold text without symbols denotes significance at p < 0.07
Table 3 BALF protein analysis at 2 months post-exposure
Protein Gr20 - High Gr5 - High Protein Gr20 - High Gr5 - High
Apo A-1 1.53 0.99 MIP - 1α 1.33 1.44
Crp Mouse 1.00 1.19** MIP - 1β 1.13 1.61**
Eotaxin 1.37* 1.52* MIP - 1γ 2.54* 4.08*
EGF Mouse 3.93 1.52 MIP - 2 1.65 2.26**
Fibrinogen 1.07 1.32 MIP - 3 1.36 1.57
GCP-2 Mouse 1.37 1.37 MMP-9 2.28 3.47
GM-CSF BLD BLD MCP-1 BLD 2.47
KC/GRO BLD BLD MCP-3 0.58 5.64**
IgA 1.05 2.01** MCP-5 BLD BLD
IP-10 1.42 2.11 PAI-1 1.02 1.36**
IL-1α 0.79 3.16 SAP BLD BLD
IL-1β BLD BLD SCF 0.78 0.94
IL-5 BLD BLD Thrombopoetin 1.90 2.52
IL-6 1.12 2.48** TIMP-1 1.20* 1.37**
IL-18 2.31 3.50* TNF-α BLD BLD
LIF 1.48 1.73* VCAM-1 1.40* 1.46*
M-CSF-1 1.13 1.48** VEGF-A 0.74 0.79
MDC 2.01* 2.38* vWF 1.41 1.46
Data in the table represent fold-increase for proteins that were significantly different for one or more groups at one or more time points post-exposure based on
RodentMap® v3.0 (Does not include CD40, CD40L, Lymphotactin, MPO, and osteopontin). BLD – below the limit of detection; ** -statistically different from Gr20
and DM; *- statistically different from DM; p < 0.05. Bold text without symbols denotes significance at p < 0.07
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absence over the majority of the time course and whether
this correlates to the lack of fibrotic development in the
lung following graphite nanoplate exposure.
A significant increase in eosinophil influx following ex-
posure to the larger graphite nanoplates, Gr20 and Gr5,
was observed, particularly at days 1 and 7 post-exposure,
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Fig. 9 Gene Expression in Lung Tissue. Realtive mRNA expression of IL-6 (Il6), MIP-2 (Cxcl2), MCP-1 (Ccl2), MDC (Ccl22), and osteopontin (Spp1) relative
to DM control at all time points post-exposure, with the exception of Spp1 which was not measured at 4 h post-exposure. Low dose groups were not
evaluated at 1 and 2 months post-exposure. *significantly different from all groups; # significantly different from DM only; ^ significantly different from
DM, Gr20-Low, Gr5-Low, and Gr1-Low; p < 0.05
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which resolved to a degree over time (Fig. 7c). The study
design does not specifically address whether this is part of
the overall inflammatory response, a specific irritancy re-
sponse, or part of a greater immune response indicative of
whether the material could act as a sensitizer or contrib-
ute to allergic responses in any way. Eotaxin, a protein in-
volved in eosinophil recruitment in inflammation and
allergic response, was significantly elevated in all groups
with Gr5 >Gr20 > CB >Gr1. In terms of T cell-related cy-
tokines that are implicated in airway disease, gene expres-
sion of IL-5, Il-13, and IL10 were elevated at 4 h post-
exposure in Gr-exposed groups, and IL-5 expression
remained elevated at 1 day post-exposure in the Gr5 and
Gr20 groups. IL-5 was also elevated 1 day post-exposure
in the BAL to a greater degree in Gr5 and Gr20 when
compared to all groups; however the elevation was transi-
ent. Shvedova et al. has shown that exposure to another
form of graphene material, graphene oxide, can alter air-
way hyperresponsiveness in a murine model of asthma
[11], however, in that particular study the Th2 cytokines
(IL-4, IL-5, and IL-13) were reduced. Further investigation
is needed to determine the physico-chemical characteris-
tics of graphene nanomaterials that may be involved in
airway disease or lack thereof.
In addition to increased inflammatory and immune
markers in the BAL fluid of Gr20- and Gr5-exposed
mice, gene expression in tissue followed a similar pat-
tern as BAL protein analysis, with increased mRNA
expression of genes encoding pro-inflammatory factors,
IL-6 (Il6), macrophage inflammatory protein (MIP)-2
(Ccl2), monocyte chemotactic protein (MCP)-1 (Cxcl2)
and macrophage-derived chemokine (MDC) (Ccl22)
(Fig. 9). The expression of these genes persisted longest
in the Gr20 and Gr5 groups, but diminished in all
groups over time. BAL fluid markers associated with
tissue remodeling (MMP-9, TIMP-1) were also increased
to a greater degree at day 1 post-exposure and persisted
longer when compared to Gr1- and CB-exposed mice.
Interestingly, gene expression of osteopontin, a potential
marker of the development of lung diseases including
fibrosis and cancer, had begun to increase by 1 and
2 months post-exposure in the Gr20 and Gr5 high dose
groups; however, no histopathological markers of dis-
ease were present at 2 months and protein levels of
MMP-9 and TIMP-2, although elevated when compared
to the DM group, were decreasing over time. Despite
the ~50 % particle clearance at 2 months, this finding
warrants examination of clearance and effects at time
points later than 2 months following lung exposure to
determine if the trend continues and fibrotic changes
occur later in recovery.
The characterization and toxicity data taken together
suggest that the pattern of toxicity for the Gr5 and Gr20
samples may have been driven by the surface reactivity
per unit surface area and/or the overall size of the material
(lateral size layer number and possibly agglomeration),
a b
c d
Fig. 10 Serum Proteins and Systemic Gene Expression. Data in the table (a) represents fold-increase for serum proteins that were significantly
different for one or more groups at 4 h and 1 day post-exposure based on RodentMap® v2.0; only high dose groups were analyzed. BLD – below the
limit of detection; astatistically different from DM only; bstatistically different DM, Gr1 - High and CB - High groups; cstatistically different from all groups;
p < 0.05. b Relative mRNA expression by qPCR of select genes in liver at 1 day post-exposures. Low dose exposures were not evaluated in liver as pilot
experiments showed no response. c Relative mRNA expression of select genes by qPCR in whole blood cells at 4 h post-exposure (d) Relative mRNA
expression of select genes by qPCR in aorta at 4 h post-exposure. *significantly different from all groups; #significantly different from DM only;
^significantly different from DM, Gr20-Low, Gr5-Low, and Gr1-Low; p < 0.05
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rather than surface area (measured in the powder form)
or particle number, where Gr5 and Gr20 were lower in
both parameters when compared to Gr1 and CB. Al-
though a large surface area is a known driving force in
toxicity of nanomaterials, this factor may be more critical
for the early acute responses; whereas with high-aspect ra-
tio materials such as graphene, shape, reactivity, dissol-
ution rate (biopersistence), and durability may be more
critical [28–31]. The agglomerate size for the larger parti-
cles raises the question of whether frustrated phagocytosis
could be playing a role in toxicity of these high aspect ra-
tio materials. However, in this study, there was no evi-
dence of granuloma formation in Gr5 or Gr20-exposed
mice, and multinucleated macrophages, although present,
were found infrequently in the BAL (Additional file 1:
Figure S1), suggesting if this was occurring it was present
at a very low level. More research is necessary to clearly
define the role of the physico-chemical properties in
toxicity as well as the mechanisms of action occurring at
the cellular and molecular level.
In general, the data presented here, relative to graphene-
based nanomaterials that have not gone through an oxida-
tion process, are in agreement with other studies whereby
pulmonary exposure causes a degree of inflammation only
at the early time points after exposure with resolution over
time [6, 8–10]. As mentioned earlier, terminology for these
materials is variable among investigators, and for the non-
oxidized forms of graphene, the studies have referred to
the materials as pristine graphene, graphene nanosheets/
nanoplates/nanoplatelets, or graphite nanosheets/nano-
plates/nanoplatelets. Shin et al. [10] found no pulmonary
toxicity associated with an estimated deposited dose of
102 or 18 μg of graphene (~0.55 μm laterally x 8 nm
thickness, referred to as graphene) in the lungs of rats at
any time point up to 28 days following a 5-day dose-
response repeated inhalation study in rats, a dose compar-
able to the amount of graphite nanoplates deposited in
the current study. The studies by Schinwald et al. [8, 9]
examined pulmonary effects following exposure to 50 μg
of graphene in mice (referred to as graphene nanoplatelets
[9] and then as pristine graphene [8]). In addition to hav-
ing a comparable dose to the high dose in the current
study, the graphene particle used by Schinwald et al. was
similar in size (~5 μm laterally x 100 nm thick;
~100 m2/g surface area) to the Gr5 primary particle di-
mensions in the current study. Graphene was found to
induce inflammation and injury at 1 day following as-
piration, with granulomatous lesions in the bronchiole
lumen and alveolar region, as well as pleural inflamma-
tion following pleural injection [9]. Responses were
followed up to 6 weeks post-exposure [8] and were
found to show resolution over time with no develop-
ment of fibrosis or increase in collagen, which is in
agreement with present study.
Further, Ma-Hock et al. [6] conducted a dose response
comparative inhalation study of MWCNT, graphene,
graphite nanoplatelets, and low surface area CB. No tox-
icity was observed following 5 days (6 h/day) inhalation
of the highest tested dose, 10 mg/m3 (~200 μg deposited
in the lung) of large graphite nanoplatelets (up to 30 μm
diameter of primary particle and > 50 μm diameter ag-
glomerated; mass median aerodynamic diameter of 2.7/
3.4 μm). Interestingly, in the study by Ma-Hock et al. [6]
the 5 day exposure to graphene (primary particle up to
10 μm lateral size and ~40 μm agglomerate size; mass
median aerodynamic diameter < 0.4 μm) at a dose of
2.5 mg/m3 for 6 h/day, with comparable deposition to
the present study, produced a low (relative to MWCNT
exposure) but significant effect up to 1 month post-exposure
with increased inflammatory mediators in lavage and
lung tissue, including osteopontin. In the present study,
there was also an increase in osteopontin in lung tissue
at 1 and 2 months post-exposure to the larger Gr5 and
Gr20 particles, although no pathology in tissue was ob-
served with the graphite nanoplates. However, in the
study by Ma-Hock et al. [6], at 10 mg/m3 of graphene,
there was a greater significant increase in inflammation
and formation of microgranulomas in the lung that per-
sisted up to 1 month post-exposure. The findings suggest
that pristine graphene was more potent than graphite
nanoplates, which produced no effect at the 10 mg/m3
dose at comparable mass doses, but is far less potent than
MWCNT which caused significant toxicity at one fourth
the dose. The authors concluded that potency did not cor-
relate well with lung burden in terms of mass, volume, or
exposed surface, where the larger aerodynamic diameter
particle (MWCNT) had the greatest toxicity; and that re-
activity or a combination of properties may be the driving
factor in potency. Although toxicity was far less for the
materials in the present studythe material with the larger
aerodynamic diameters (Gr5 and Gr20) and greater re-
activity per m2 were more toxic, suggesting size and/or
reactivity as possible factors.
Other studies of graphene nanoplate materials have
found adverse effects following pulmonary exposure [4, 7].
Park et al. [7] examined lung responses in mice following
intratracheal administration of a graphene particle similar
in lateral size and surface area of Gr1 at doses of 2.5 and
5.0 mg/kg in mice, referred to as pristine graphene. Dif-
ferences in the current study versus the findings in Park
et al. [7] may be attributable to dose, where the highest
dose in the present study of 40 μg per mouse was
equivalent to only 2.0 mg/kg, and possibly to differences
in the graphitic nature and defects present in the particles,
where the particle used by Park et al. [7] had fewer layers
and may have been lower in defects and disorder in struc-
ture. In a study by Duch et al. [4], mice were treated by as-
piration with differing graphene materials referred to as
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dispersed pristine graphene (in 2 % Pluronic F 108NF®),
aggregated pristine graphene, or graphene oxide flakes, at
50 μg per mouse, a dose comparable to that of the current
study. Aggregated pristine graphene was generally less
toxic than graphene oxide, but more toxic than dispersed
pristine graphene at 1 day post-exposure. At 21 days
post-exposure, histology showed that only the aggre-
gated material caused what was described as a “patchy”
fibrosis, although there were no significant increases in
collagen as determined by Sirius red staining in any of
the treatments. A more severe, persistent inflammation
was evident in lungs of mice exposed to graphene oxide.
Particles used in this study were small in both lateral
dimension (~200–500 nm) and thickness (1.2–5 nm)
when compared to the Gr20, Gr5, and Gr1 in the present
study. Interestingly, the aggregated material, which
would presumably have a greater lateral dimension, or
aerodynamic diameter, within a given aggregate, pro-
duced a greater effect than the dispersed material,
suggesting a role of agglomerate size in toxicity, which
is similar to the possible size-dependent effects observed
in the current study.
The studies discussed above suggest that the size,
graphitic nature/purity, and possible related reactivity
are important factors for pulmonary toxicity and support
the findings of the present study that shows that size/ag-
glomeration and/or reactivity are factors in toxicity. The
current study, however, only examined non-oxidized ma-
terials, and the toxicity that resulted showed resolution
over time. It is well understood that composition plays a
critical role in toxicity. In general, in vivo studies have
demonstrated that the oxidized forms of graphene nano-
materials cause a greater pulmonary toxicity than that of
what was referred to as pristine graphene or graphite
nanoplates/nanoplatelets [4, 5, 11]. As discussed above,
Duch et al. [4] found graphene oxide to be more toxic
than the pristine form of graphene. Li et al. [5] demon-
strated that respiratory exposure to graphene oxide in
mice resulted in a dose-dependent increase in lung tox-
icity and development of fibrosis at 3 months post-
exposure to a dose of 10 mg/kg. Graphene oxide has
also been shown to cause airway remodeling and hyper-
responsiveness in an OVA-induced asthma model in
mice when administered prior to the sensitization phase
of the model [11]. The same study also determined that
graphene oxide caused a decrease in Th2 cell responses
in the asthma model. In vivo data showing increased
toxicity of oxidized graphene nanomaterials are further
substantiated by numerous in vitro studies in a host of
different cell types as reviewed in detail by Seabra et al.
[32] and Bianco [33]. Studies are underway by our la-
boratories to examine pulmonary and systemic toxicity
due to variations in oxidation state along the life-cycle of
a given graphene nanomaterial.
Conclusions
In conclusion, the findings of the present study suggest
that pulmonary exposure to graphite nanoplates of simi-
lar composition but with larger lateral dimensionsand
increased surface reactivity per unit surface area cause-
dinjury and inflammation in the lung as early as 4 h
post-exposure. The increase peaked at 1 day and persisted
up to 1–2 months following exposure, with a trend for a
decrease over time The pattern of inflammation differed
from that of the smaller graphite nanoplate sample and
from carbon black nanoparticles, both of which were
higher in surface area when compared to the larger mate-
rials. These findings suggest a role for surface properties
and/or lateral particle size, and possibly agglomerate size,
in initiating toxicity. The pulmonary and systemic effects
observed early after exposure did show resolution over
time for all groups. Taken together with results of studies
on other graphene-based nanomaterials, toxicity of non-
oxidized forms of graphenes may depend on size and sur-
face reactivity, as well as agglomeration of materials, and
are likely less toxic than various forms of graphene oxides,
for which toxicity has been shown to be more persistent
with less resolution over time, and may be dependent on a
different set of physicochemical characteristics including




Three different sizes of graphite nanoplates (Gr) were
provided by Cabot Corp., Billerica, MA. The samples
were manufactured to have primary particle dimensions
of 20 μm lateral (Gr20), 5 μm lateral (Gr5), and < 2 μm
lateral (Gr1). Carbon black (CB), ~15 nm diameter, was
purchased commercially (Printex 90, Degussa- Heuls,
Germany) to serve as a particle control. FESEM (Hitachi
Model S-4800, Japan) was used to visualize and verify
size of the particles in the dry powder form.
Surface area
Surface area was measured on the powder form of the
materials by gas adsorption using a Quantachrome
NOVA 2200e surface area analyzer and ultra-high purity
nitrogen adsorbate. Specific surface area was determined
by using the multipoint (7 recorded points) Brunauer,
Emmett, and Teller (BET) method for relative pressures
between 0.05 and 0.35 [34].
Structural analysis
XRD was performed to determine the crystalline phase
of graphite present, as well as the number of layers
present in each sample. Room temperature powder x-ray
diffraction (XRD) patterns were acquired with a Rigaku
diffractometer (D/Max B) equipped with CuKα source
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(λ = 1.54185 Å) and the d-spacings and 2ϴ positions of
the observed lines were compared to published reference
patterns. Typically, scans covered the 2ϴ range of 5° to
70° and were collected at a step size of 0.06° with a
counting time of 5 s at each step. Interpretation of the
XRD patterns was based on the basic Bragg’s law for dif-
fraction: 2d sinϴ = nλ, where d is the separation of the
(hkl) planes responsible for the particular (hkl) Bragg
peak, ϴ is the Bragg angle of a peak, n is the order of
diffraction (1, 2, 3, etc.), and λ = 1.54185 Å is the Cu Kα
wavelength of the x-rays used in these investigations.
The following information about the graphite structure
was extracted from the XRD patterns: form (2H or
3R), degree of graphitization, crystallite size, and num-
ber of layers. The lattice parameters of 2H graphite
are: c = 6.708 Å, a = 2.4614 Å, c = 2 d(002) and the
degree of graphitization g is defined as [35, 36].
g ¼ 3:440−d 002ð Þ
3:440−3:354
ð1Þ
The apparent crystallite size along the c- (Lc) and a- (La)
directions are given by [35, 36].









β is the instrument-corrected full-width at half max-
imum (FWHM) of the (002) line near 2 ≈ 26° in ra-
dians for LC; the FWHM for the (101) or (112) in
radians are used for determining La. By expressing Bragg’s
law in terms of λ, equation 2 for LC can be used to derive
the number of graphene layers along the c-direction.
#layers Nc ¼ Lcd 002ð Þ ¼ 1:8 tanθ=β: ð4Þ
Particle preparation in DM
For in vivo studies, aspiration requires the suspension of
the particles in a physiologically compatible vehicle for
delivery to the animal. Gr and CB samples were suspended
in a well-characterized DM (0.6 mg/ml mouse serum albu-
min + 0.01 mg/ml dipalmitoyl phosphotidyl choline in
phosphate buffered saline [14]) designed to mimic the fluid
lining of the lung at a concentration of 0.8 mg/ml, equiva-
lent to the high dose (40 μg particle/50 μl DM) for in vivo
studies. The samples were then sonicated at 10 W for 5 s
each with a probe sonicator. The low dose (4 μg/50 μl) of
Gr was prepared by diluting the high dose 1:10 in DM.
Particle preparations were made on the day of use for both
characterization and in vivo studies.
Agglomerate size distribution in DM
Light micrographs of the high dose aspiration prepara-
tions (0.8 mg/ml DM) of Gr20, Gr5, Gr1, and CB were
acquired (60 and 100x magnification). Corresponding
agglomerate/particle diameter size measures made
from point count measurements on the light micro-
scope (n = 214–491 measures per sample) were acquired
and the mean agglomerate size, measured from the great-
est distance across agglomerates, and distribution were
determined. DLS (Microtrac Inc., San Diego, CA) was
used to verify the size range for the smaller particle sam-
ples, Gr1 and CB. Gr20 and Gr5 could not be quantified
with DLS due to size and density of agglomerates.
Zeta potential in DM
Zeta potential was determined by electrophoretic mobil-
ity. For each material, a stock suspension (1 mg/mL)
prepared in DM was subjected to ultrasonic agitation
using a 3 mm probe tip for 5 min (delivered energy =
1650 J) and further diluted using fresh DM. The DM
had pH 7.4, as determined using a calibrated electrode
attached to a volt meter. The parameters for the dispers-
ant were based on PBS, the major constituent of DM
(refractive index = 1.334, viscosity = 0.9110 cP, dielectric
constant = 79.0, and Smoluchowski approximation, f(ka)
value = 1.5). All measurements were performed at 25 °C
using a Malvern Zetasizer Nano ZS90 (Worcestershire,
UK) equipped with a 633 nm laser at a 90° scattering
angle. Samples were equilibrated inside the instrument
for two minutes, and five measurements, each consisting
of five runs, were recorded.
Surface reactivity
Generation of hydroxyl radicals on the particle surface
as an indicator of surface impurities implying reactivity
was evaluated by ESR using an EMX spectrometer
(Bruker Instruments Inc., Billerica, MA) and a flat cell
assembly. This technique involved the addition-type re-
action of a short-lived radical with a diamagnetic com-
pound (spin trap) to form a relatively long-lived free
radical product (the spin adduct), which can be observed
by conventional ESR [37]. For this study, hydroxyl radical
was generated from a Fenton-like reaction system after
the Gr or CB samples were suspended in dispersion media
(at a dose equivalent to the high dose used in this study)
and were combined with H2O2 [1 mM] in the presence
of 100 mM of the spin trap 5,5-dimethyl-1-pyrroline
N-oxide (DMPO) and PBS to a final volume of 1 ml.
Reactions were allowed to incubate 3 min at room
temperature before measurement and then transferred
to a flat cell for ESR measurement. Signal intensity of
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the spin adduct, which corresponds to the amount of a
given radical species, was determined by integration of
the characteristic wave form for that radical. The wave
form was then measured and quantified and compared
to a positive control at the same concentration (coal
containing α-quartz silica).
To detect the free radicals generated by particles, a
previously reported method utilizing DCFH was employed
[38, 39]. Briefly, DCFH-diacetate was chemically hydro-
lyzed to generate DCFH using 0.01 N NaOH for 30 min
at room temperature. This solution was further neutral-
ized using 0.1 M PBS. Nanoparticle suspensions were
prepared in DM as above. To evaluate a dose response,
a reaction mixture containing a final concentration of
10 μM DCFH (with and without 0.1 unit/ml horse rad-
ish peroxidase) was added to wells containing nanopar-
ticles at 6.25, 12.5, 25 and 50 μg/ml. All experiments
were conducted in triplicate with water, DM and H2O2
as controls. The kinetics of DCFH oxidation was moni-
tored for 60 min with readings every 10 min at 485 nm
excitation and 530 nm emission. All measurements
were conducted with under low light exposure.
A third cell free assay system was used based on anti-
oxidant (DTT, dithiothreitol) depletion to determine the
oxidative potential of the materials used in the current
study. This method has been used to determine the oxi-
dation potential of carbon-based and metal oxide nano-
particles by several groups [40–43]. The oxidative capacity
of the nanomaterials was determined by its ability to con-
sume DTT. The DTT content left in the reaction mixture
was determined by reacting it with 5,5′-dithio-bis-(2-
nitrobenzoic acid) (DTNB). Reaction with DTNB is rapid
and stoichiometric resulting in formation of 2-nitro-5-
thiobenzoate (TNB), a colored by product that can be
calorimetrically detected by measuring absorption at
412 nm. Nanomaterials suspensions were prepared in
DM as described above. The reaction was conducted
with samples in triplicates with PBS and DM as con-
trols in a 96-well black plate with optical bottom. The
microplate was shielded from light and was placed
under constant agitation. 25 μl of 50 μg/ml nanoparti-
cle suspension was reacted with 25 μl of 100 μM DTT.
After 30 min of reaction, the reaction was quenched
using 50 μl of 10 % trichloroacetic acid. This reaction
mixture was further neutralized by addition of 180 μl of
Tris-HCl buffer pH 8.9. The DTT left in the reaction
mixture was determined by exposing it to 5 μl of
10 mM DTNB in water and calorimetrically determined
by absorption at 412 nm. As numerous studies have
shown that surface area is an important dose metric for
nanoparticle-related toxicity, in addition to plotting the
DTT consumption based on nanoparticle mass (nM/μg),
we have also plotted the DTT consumption based on
surface area (nM/M2) calculated through BET.
Animals
Specific pathogen-free, male C57BL/6 J mice, ~8 weeks
of age, were obtained from Jackson Laboratory (Bar
Harbor, ME) for use in this study. All mice were individu-
ally housed in polycarbonate ventilated cages with
HEPA-filtered air in the Association for Assessment
and Accreditation of Laboratory Animal Care (AAALAC)
-approved National Institute for Occupational Safety and
Health (NIOSH) Animal Facility, and provided food
[Harlan Teklad Rodent Diet 7913 (Indianapolis, IN)]
and tap water ad libitum in a controlled humidity and
temperature environment with a 12 h light/dark cycle.
Animals were allowed to acclimate for 1 week in the fa-
cility prior to use in the study. All procedures in the
study comply with the ethical standards set forth by the
Animal Welfare Act (enforced by the United States De-
partment of Agriculture) and the Office of Laboratory
Animal Welfare (OLAW). The studies were approved
by the NIOSH Health Effects Laboratory Division (HELD)
Institutional Animal Care and Use Committee within
the Center for Disease Control (Public Health Services
Assurance Number A4367-01) in accordance with an
approved institutional animal protocol (protocol num-
ber 12-JR-M-001).
In vivo exposure and study design
To evaluate pulmonary and extrapulmonary toxicity fol-
lowing lung exposure to a well-characterized group of
graphene nanomaterials, a dose-response time course
study in mice was conducted. On day 0, two sets of male
C57BL/6 J mice were exposed by pharyngeal aspiration
to 4 or 40 μg of Gr20, Gr5, or Gr1 in DM, DM alone
(vehicle control), or 40 μg of CB (particle control). Mice
were fully anesthetized with isoflurane, placed on a
slanted board and suspended by the incisors. The mouth
was opened and tongue moved aside, while a 50 μl ali-
quot of sample was pipetted to the base of the tongue.
The animal was restrained until two full breaths were
completed (but not longer than 15 s), then placed on its
side and monitored for recovery from anesthesia. Animal
exposures were conducted utilizing a randomized block
design (n = 8 per group per time point with the exception
of the 4 h time point where the group size was n = 6).
Mice were humanely euthanized with an overdose of so-
dium pentobarbital (100–300 mg/kg bwt; Sleepaway; Fort
Dodge Animal Health; Madison, NJ) at 4 h, 1 day, 7 days,
1 month, and 2 months post-exposure. The lungs of one
set of mice underwent BAL (n = 6–8 per group per time
point) to collect fluid and cells for pulmonary toxicological
analyses. In the second set of mice (n = 6–8 per group per
time point), the left lung was ligated and frozen in liquid
nitrogen for RNA analysis while the right lungs were fixed,
sectioned, and stained for histopathology and morpho-
metric analysis of deposition and clearance. Blood, heart,
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aorta, and liver were collected to evaluate cardiovascular
parameters of toxicity. Tissues for RNA isolation were
snap-frozen in RNA-free tubes in liquid nitrogen at the
time of tissue collection.
Pulmonary deposition/clearance and histopathology
The right lungs of mice were pressure fixed in 10 %
neutral-buffered formalin, paraffin embedded, and sec-
tioned for histopathological and morphometric analyses.
Tissue sections from right lungs of control mice and
mice treated with the high doses of Gr20, Gr5, Gr1, and
CB were stained with Sirius red and hematoxylin. The
distribution of particle at 4 h post-exposure in the lungs
was determined by counting the occurrence of Gr or CB
under an eyepiece point counting overlay using standard
morphometric point counting methods [44]. Point count-
ing categories were subdivided into points over Gr or CB
in airway or points over Gr or CB in the alveolar region.
Airway regions were defined as those containing airway
tissue (airway epithelial cells-basement membrane and
tissues of the broncho-vascular cuff), airway lumen, and
associated blood vessels greater than 25 μm. Alveolar
regions were those containing alveolar tissue, alveolar
macrophages, and alveolar air space. To accomplish the
counting, the optical system for enhanced darkfield mi-
croscopy was employed that consisted of high signal-
to-noise, darkfield-based illumination optics adapted to
an Olympus BX-41 microscope (CytoViva, Auburn, AL
36830), in combination with light microscopy. The use
of this microscope enables evaluation of nanomaterials
as small as 10 nm, allowing for detection of the smaller
agglomerates described in this study [45, 46]. An eye-
piece counting overlay consisting of 11 by 11 lines (121
total points for each throw of the overlay) was used
with a 100x oil immersion objective. A grid pattern for
throws of the counting overlay was used in order to
insure a uniform sampling of the section, which did not
overweight interior points. The counting overlay throws
of the eyepiece were positioned over the section at 12
uniformly spaced grid points in both X and Y co-ordinates.
These 12 grid points were determined using the stage mi-
crometer scale to measure the X and Y bounds of the sec-
tion. Using the bounding rectangle of these co-ordinates a
3 by 4 grid was selected and the 12 intersections were used
as the center point for each of the eyepiece counting over-
lay throws. For each animal, three sections were counted,
and the counts for the airway and alveolar region were
summed. Each counting category was divided by this total
and multiplied by 100 to express the results as a percentage
of total lung burden. Similar analyses were performed at
7 days and 2 months post-exposure to evaluate clearance of
the material from the lungs in total and by region.
For histopathological analysis, two sections of right
lung tissue from each animal in each treatment group,
both low and high doses, as well as controls were evalu-
ated: one section was stained with hematoxylin and
eosin (H&E) for parameters of injury and inflammation,
and another section was trichrome-stained for analysis
of fibrosis (n = 6 per group per time point). Slides were
quantitatively analyzed by a certified veterinary path-
ologist at Charles River Laboratories (Frederick, MD),
who was blinded to the treatment groups. Indices of in-
flammation, injury, and fibrosis were scored on scale of
0–5, where 0 = no observed effect, 1 =minimal response,
2 =mild response, 4 =moderate response, and 5 = severe
response.
BAL Cellular and Fluid (BALF) analysis
In a separate group of mice, BAL was performed on the
lung in order to obtain pulmonary cells and fluid for
analysis of indicators of lung injury, inflammation, and
cellular activity (n = 8 per group per time point). Follow-
ing euthanasia, the trachea was cannulated, the chest
cavity was opened, and BAL was performed on the
whole lungs. The acellular fraction of the first lavage was
obtained by filling the lung with 0.6 ml PBS, massaging
for 30 s and withdrawing. This concentrated aliquot was
retained, kept separately, and was designated as the first
fraction of BALF. The following aliquots were 0.6 ml in
volume, instilled once with light massaging, withdrawn,
and combined until a 2.4 ml volume was obtained. For
each animal, both lavage fractions were centrifuged
(10 min, 1600 rpm), the cell pellets were combined and
resuspended in 1 ml of PBS for cell counts and differ-
entials, and the acellular fluid from the first fraction
was retained for analysis of LDH activity and protein
content.
The total numbers of BAL cells collected from mice
were counted using a Coulter Multisizer II (Coulter
Electronics; Hialeah, FL). Cell differentials were performed
to determine the total number of alveolar macrophages
(AM), neutrophils, lymphocytes, and eosinophils. Briefly,
105 cells from each mouse were spun down onto slides
with a Cytospin 3 centrifuge (Shandon Life Sciences Inter-
national; Cheshire, England) and labeled with Leukostat
stain (Fisher Scientific; Pittsburgh, PA) to differentiate cell
types. Two hundred cells per slide were counted, and the
percentages of AM, neutrophils, lymphocytes, and eosino-
phils were multiplied by the total number of cells to calcu-
late the total number of each cell type. In addition, images
of the cytospin were collected at 40x magnification to
illustrate particle burden in macrophages at various
time points post-exposure.
Measurements of LDH activity in BALF was obtained
using a Cobas Mira analyzer (Roche Diagnostic Systems;
Montclair, IN). LDH activity was quantified by detection
of the oxidation of lactate coupled to the reduction of
NAD+ at 340 nm. A battery of 60 proteins in BALF was
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measured using RodentMap® v2.0 for the 1 day, 7 days,
and 1 month post-exposure time points and RodentMap®
v3.0 for the 2 month time point (Myriad RBM, Austin,
TX) (n = 4–6 per group per time point analyzed).
RNA isolation and relative mRNA expression via qPCR
RNA was isolated from frozen lung and liver using the
RNeasy Mini Kit (Qiagen, Valencia, CA, USA) following
homogenization using a Tissue Lyser II (Qiagen, Valencia,
CA). The aorta, following homogenization with the Tissue
Lyser II, was isolated using the RNeasy fibrous tissue mini
kit (Qiagen, Valencia, CA). Whole blood RNA was isolated
using the Mouse RiboPure™-Blood RNA Isolation Kit
(Ambion, Austin, TX) according to manufacturer’s
directions and globin RNA was removed using the
GLOBINclearTM kit (Ambion, Austin, TX). A 2 μl ali-
quot of each RNA sample was quantified using a
NanoDrop ND-1000 spectrophotometer (NanoDrop
Technologies, Inc., Wilmington, DE). Evaluation of gene
expression was determined by standard 96-well technology
using the StepOne™ (Applied Biosystems, Carlsbad, CA,
USA) with pre-designed Assays-on-Demand™ TaqMan®
probes and primers. Assessed genes for the lung in-
cluded IL-6 (Il6, Mm00446190_m1), MIP-2 (Ccl2,
Mm00441242_m1), MCP-1 (Cxcl2, Mm00436450_m1),
MDC (Ccl22, Mm00436439_m1), and osteopontin (Spp1,
Mm00436767_m1); liver genes included haptoglobin (Hp,
Mm0516884_m1), metallothionein 1 (Mt1, Mm00496660_g1),
serum amyloid A1 (Saa1, Mm00656927_g1), and serum
amyloid P (Apcs, Mm00488099_g1); genes for whole
blood cells included IL-6 (Il6, Mm00446190_m1) Il-1β
(Mm00434228_m1), CSF-1 (Mm00432686_m1), S100a8
(Mm00496696_g1), heme oxygenase-1 (Hmox1 Mm00516005_
m1); and genes for aorta included metallothionein 2
(Mt2, Mm00809556_s1, heme oxygenase-1 (Hmox1,
Mm00516005_m1), E-selectin (Sele, Mm00441278_m1)
Using 96 well plates, one μg of total RNA was reverse
transcribed using random hexamers (Applied Biosystems)
and Superscript III (Invitrogen, Carlsbad, CA). Nine μl of
cDNA (1/10) was then used for gene expression determin-
ation. Hypoxanthine-guanine phosphoribosyltransferase
was used as an internal reference for all tissues and
18S for whole blood cells. Relative gene expression
was calculated using the comparative threshold method
(2-ΔΔCt) with vehicle-treated mice serving as the reference
group [47].
Relative mRNA expression via TaqMan® arrays
An initial screen utilizing pre-designed TaqMan® arrays
that included 93 target genes and 3 housekeeping
genes was done for dispersion media, Gr1 high, Gr5
high, and Gr20 high (n = 3 or 4 per group). Lung (4 h
and 1 day), liver (1 day), and whole blood cells (4 h)
were screened for alterations in gene expression. The
complete list of genes is included in the supplemental
section (Additional file 3: Table S2). Samples were run
according to the Applied Biosystems TaqMan® array
user bulletin using the ABI 7900 (Applied Biosystems).
A total of 1000 ng of total RNA converted to cDNA in
a final volume of 200 μl (96a format) was used. The
housekeeping gene contained within the LDA used for
normalization was hypoxanthine-guanine phosphoribosyl-
transferase (HPRT). Relative gene expression was calcu-
lated using the comparative threshold method (2-ΔΔCt)
with vehicle treated mice serving as the reference group.
Serum protein analysis
Proteins quantified in serum collected 4 h and 1 day
post-exposure were determined by Myriad/Rules
Based Medicine (Austin, TX) by multiplex immunoassay
RodentMap® v2.0.
Statistics
Results for BAL analyses were expressed as means +
standard errors and an analysis of variance (ANOVA)
was performed to determine significant difference among
treatment groups. Data for BAL protein parameter ana-
lyses were log transformed before testing for significance.
Significant differences among groups were assessed by the
Student-Newman-Keuls method. For morphometric stud-
ies, Bartlett’s test was used to test for homogeneity of vari-
ances between groups. When significant F values were
obtained, individual means were compared to control
using Duncan’s multiple comparison procedure. Because
data from histopathology studies were inherently categor-
ical, a nonparametric analysis of variance was performed
using SAS, Inc. statistical programs using the Wilcoxon
rank sum test. For all analyses, significance was set at
p < 0.05. Data from Taqman® arrays and qPCR were log
transformed and analyzed by one-way ANOVA gener-
ating a least squares mean table by Student’s t-test
using JMP® Statistical Discovery Software. Differences
were considered statistically significant at p < 0.05.
Additional files
Additional file 1: Figure S1. Images of cells recovered by BAL from
animals exposed to DM or 40 μg of Gr20, Gr5, Gr1, or CB, at 4 h, 7 days,
and 2 months post-exposure illustrating particle burden in macrophages
from the alveolar region. (PDF 1663 kb)
Additional file 2: Table S1. List of total proteins analyzed by RodentMAP®
analyses, abbreviations, and alternate nomenclature. (PDF 32 kb)
Additional file 3: Table S2. Genes contained in the pre-designed
TaqMan® array. (PDF 22 kb)
Additional file 4: Table S3. Differentially expressed genes in lung
tissue following exposure to 40 μg of Gr20, Gr5, or Gr1. (PDF 38 kb)
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